BUSINESS BRIEF
The comapny is into manufacturing of Sterile Liquid Injectable products. The company has established a state-of-the-art manufacturing unit for injectable drug formulations in the industrial estate of western India, setting a new standard for quality and innovation.
Key Highlights:
- Location: Well -connected and easily accessible by rail, road, and air.
- Facility Overview: State -of -the-art manufacturing site is equipped with Ampoule lin, Vial line, and a Lyophilizer/Freeze Dryer. It has all the necessary utilities and employ ultra-modern machinery to meet production capability and capacity demands
- Staff: Total staff of more than 200 people With company and contract staff.
- Quality Control Area: Dedicated Quality Control (QC) area equipped to handle raw material testing, in-process
testing, and finished product testing, guaranteeing the highest product quality. - Dedicated Warehouse for Secondary Packaging Materials
Products & Services
Injectables
Proposal
Industry
Pharmaceuticals
Sub Industry
Pharmaceutical Manufacturing (Injectables & IV Solutions)
Nature of Business
B2B
Sector
Manufacturing (Own Brand & Contract Manufacturing)
Reason for sell-off
Strategic Realignment or Pursuing New Opportunities
Location
India
Region
Western
Open For Dilution
51-75 % (Majority)
Top Customer
Deal Size
INR 20 - 25 Cr
Justification
Growth capital
Business Operation Information
Financial Information |
2025 (in INR Cr) | 2024 (in INR Cr) | 2023 (in INR Cr) |
|---|---|---|---|
Sales |
16 | 26 | 47 |
EBITDA |
|||
PAT |
